Sign in
CMHC Stock Price, Chart, Stats & News
Cosmo Pharmaceuticals N.V.
Save
Cosmo Pharmaceuticals N.V. (CMHC) is a dividend-paying stock with a current dividend yield of 3.38% as of Aug 21, 2026. It pays 1.95 CHF per share over the trailing twelve months and distributes annually.
CMHC chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
Related lists
Similar securities
Based on sector and market capitalization
Report issue